| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/02/2010 | US7655408 PCA3 messenger RNA species in benign and malignant prostate tissues |
| 02/02/2010 | US7655407 Using variation in physical properties of desorbed fine particle probe as evaluative tool in monitoring probe/ligand interaction; disease diagnosis |
| 02/02/2010 | US7655406 Expression vector comprising nucleotide sequences coding non-structural proteins of hepatitis virus for use in identifying modulators which prevent viral infections |
| 02/02/2010 | US7655405 Generating a signal indicative of the presence of a target nucleic acid in a sequence by incubating the sample containing the target with a reverse transcriptase, a primer and a probe |
| 02/02/2010 | US7655404 Simple, rapid and ultrasensitive method and device for the detection and/or quantification of target nucleic acids; efficient methods for direct identification and/or analysis of target genes in the total mRNA present in a sample |
| 02/02/2010 | US7655403 CHD7 gene polymorphisms are associated with susceptibility to idiopathic scoliosis |
| 02/02/2010 | US7655402 Diagnoses and therapeutics for cancer |
| 02/02/2010 | US7655401 Methods for identifying subjects susceptible to ataxic neurological disease |
| 02/02/2010 | US7655400 Substance capable of accelerating nucleotide chain exchange reaction |
| 02/02/2010 | US7655399 Methods for prenatal diagnosis of chromosomal abnormalities |
| 02/02/2010 | US7655398 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 02/02/2010 | US7655397 Selections of genes and methods of using the same for diagnosis and for targeting the therapy of select cancers |
| 02/02/2010 | US7655396 Methods for detecting receptor modulator activity |
| 02/02/2010 | US7655395 Genes, cloned and amplified in bacterial cells; gene expression in insect cells shows that recombinant protein folds into a functional calcium release channel; drug screening of insecticides and pesticides; overcoming toxic effects of expressing recombinant proteins in host cells |
| 02/02/2010 | US7655394 Selective detection of HCV NS2/3 autocleavage activity hence; identification of potential HCV inhibitor compounds |
| 02/02/2010 | US7655269 Integrated nanomechanical sensor array chips |
| 02/02/2010 | US7655246 Chlamydia protein, gene sequence and uses thereof |
| 02/02/2010 | US7655245 Meningococcal serotype polypepties for use in diagnosis, prevention and treatment of microorganismal infection |
| 02/02/2010 | US7655234 Inhibiting growth of a solid tumor cell that expresses the protein; cancer diagnosis |
| 02/02/2010 | US7655223 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 02/02/2010 | US7655184 Delayed and diffused flow rapid confirmatory immunological testing apparatus and method |
| 02/02/2010 | US7655129 Using electric pulse to accelerate binding of target analytes to capture ligands on sself-assembled monolayers; biosensors |
| 02/02/2010 | US7655119 Meter for use in an improved method of reducing interferences in an electrochemical sensor using two different applied potentials |
| 02/02/2010 | CA2585164C Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses |
| 02/02/2010 | CA2519314C Chromogenic substrate with a ph indicator dye |
| 02/02/2010 | CA2479494C Compositions and methods associated with pro5725 and its use for the diagnosis of lung and colon tumor |
| 02/02/2010 | CA2451394C Il-4 receptor sequence variation associated with type 1 diabetes |
| 02/02/2010 | CA2439051C Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 02/02/2010 | CA2428214C Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 02/02/2010 | CA2427029C Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 02/02/2010 | CA2426043C Modulating angiogenesis |
| 02/02/2010 | CA2366468C Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 02/02/2010 | CA2355893C Antiuracil monoclonal antibody |
| 02/02/2010 | CA2302779C Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 02/02/2010 | CA2295545C Composition and method for staining cellular dna |
| 02/02/2010 | CA2230885C Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 02/02/2010 | CA2196286C Parallel selex |
| 02/02/2010 | CA2160937C Survival motor neuron (smn) gene: a gene for spinal muscular atrophy |
| 02/02/2010 | CA2146974C Direct selection of cells by secretion product |
| 01/31/2010 | CA2674011A1 Pharmaceutical compounds |
| 01/28/2010 | WO2010012002A1 Methods and systems for genetic analysis of fetal nucleated red blood cells |
| 01/28/2010 | WO2010011965A2 Identifying high risk clinically isolated syndrome patients |
| 01/28/2010 | WO2010011901A1 Detection of rna-dna duplex molecules |
| 01/28/2010 | WO2010011898A1 Method for treatment of bone diseases and fractures |
| 01/28/2010 | WO2010011894A1 Vh4 codon signature for multiple sclerosis |
| 01/28/2010 | WO2010011884A2 Novel nucleic acid-based molecular probes |
| 01/28/2010 | WO2010011852A1 Method and system for manufacturing integrated fluidic chips |
| 01/28/2010 | WO2010011839A1 Methods of identifying modulators of ubiquiting ligases |
| 01/28/2010 | WO2010011803A1 Molecular markers linked to ppo inhibitor tolerance in soybeans |
| 01/28/2010 | WO2010011683A2 Methods for the cytological analysis of cervical cells |
| 01/28/2010 | WO2010011642A2 Methods and compositions using splicing regulatory proteins involved in tumor suppression |
| 01/28/2010 | WO2010011506A2 Risk factors and a therapeutic target for neurodegenerative disorders |
| 01/28/2010 | WO2010011407A2 Methods of generating patterned soft substrates and uses thereof |
| 01/28/2010 | WO2010011358A2 Method and medium for detecting the presence or absence of staphylococcus aureus in a test sample |
| 01/28/2010 | WO2010011304A2 Crystal structure of bifunctional transglycosylase pbp1b from e.coli and inhibitors thereof |
| 01/28/2010 | WO2010011283A2 Fus/tls-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases |
| 01/28/2010 | WO2010011281A2 Methods and compositions for the diagnosis and treatment of cancer |
| 01/28/2010 | WO2010011169A1 Modified pichia strain |
| 01/28/2010 | WO2010010966A1 Nucleoside triphosphate derivative, nucleic acid probe, multilabeled nucleic acid probe, method for production of multilabeled nucleic acid probe, and method for detection of target nucleic acid |
| 01/28/2010 | WO2010010951A1 Method for detection of expression of indicator mrna acting as indicator for endometriosis-related diseases, and probe for use in the method |
| 01/28/2010 | WO2010010914A1 Method for collection of nucleic acid from fecal sample, method for analysis of nucleic acid, and apparatus for treatment of fecal sample |
| 01/28/2010 | WO2010010887A1 Tissue expression promoter |
| 01/28/2010 | WO2010010881A1 Blood component measurement method utilizing hemolyzed whole blood, and kit for the method |
| 01/28/2010 | WO2010010697A1 Method for testing on risk of cardiac infarction |
| 01/28/2010 | WO2010010672A1 Novel oncogene nrf2 |
| 01/28/2010 | WO2010010670A1 Technique for estimating cell conditions and image processor for cell observation |
| 01/28/2010 | WO2010010582A1 Antibiogram method and kit |
| 01/28/2010 | WO2010010312A1 Method for detecting chromosomal abnormalities |
| 01/28/2010 | WO2010010213A1 Gene expression profile as an endometrial receptivity marker |
| 01/28/2010 | WO2010010211A2 Disposable amperometric biosensor, production method thereof and method for determining the presence of analytes in foods |
| 01/28/2010 | WO2010010201A1 Gene expression profile as a marker of endometrial receptivity |
| 01/28/2010 | WO2010010194A1 Kit and method for evaluating detection properties in amplification reactions |
| 01/28/2010 | WO2010010096A2 Method for producing haploid, doubled haploid and/or dihaploid plants by gynogenesis |
| 01/28/2010 | WO2010010083A1 Selective enrichment medium for carbapenem-resistant bacteria |
| 01/28/2010 | WO2010010057A2 Use of genetic markers for identifying the response to interferon treatment in multiple sclerosis patients |
| 01/28/2010 | WO2010010027A1 Antifungal compounds |
| 01/28/2010 | WO2010009886A1 Fluorescently or spin-labeled kinases for rapid screening and identification of novel kinase inhibitor scaffolds |
| 01/28/2010 | WO2010009534A1 Methods for the treatment, prevention and diagnosis of lipid metabolism associated diseases |
| 01/28/2010 | WO2010009500A1 Improved vegetable oils and uses therefor |
| 01/28/2010 | WO2010009499A1 Improved cottonseed oil and uses |
| 01/28/2010 | WO2010009494A1 A diagnostic method |
| 01/28/2010 | WO2009149308A3 Compositions and methods for rapid one-step diagnosis |
| 01/28/2010 | WO2009149166A3 Methods and compositions for the diagnosis and treatment of proliferative disorders |
| 01/28/2010 | WO2009148552A3 Methods and compositions for treating disease |
| 01/28/2010 | WO2009148528A3 Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatment |
| 01/28/2010 | WO2009147658A3 Compositions and methods for diagnosis, prognosis and treatment of mesothelioma |
| 01/28/2010 | WO2009145830A3 Signatures of radiation response |
| 01/28/2010 | WO2009145828A3 Two slow-step polymerase enzyme systems and methods |
| 01/28/2010 | WO2009142483A3 Genetic markers predicting age at menopause |
| 01/28/2010 | WO2009140665A3 Identification of a molecular signature for antipsychotics and serms |
| 01/28/2010 | WO2009139915A3 Novel targets for regulation of angiogenesis |
| 01/28/2010 | WO2009134814A3 Identification of centromere sequences and uses therefor |
| 01/28/2010 | WO2009134714A3 Fusion molecules of rationally-designed dna-binding proteins and effector domains |
| 01/28/2010 | WO2009131964A3 Method of detecting calcifying nanoparticles and susceptibility to calcifying nanoparticle formation |
| 01/28/2010 | WO2009130465A3 Genetic markers for adhd, alcoholism and further psychic disorders |
| 01/28/2010 | WO2009129454A3 Predicting risk of major adverse cardiac events |
| 01/28/2010 | WO2009126883A3 Nucleic acid binding substance containing catalytic nucleation nanoparticles |
| 01/28/2010 | WO2009079606A3 Microrna-induced es-like cells and uses thereof |
| 01/28/2010 | WO2008131163A8 Enzymatic anticancer therapy |
| 01/28/2010 | WO2008095056A3 Method for identifying a compound that modulates sir2 protein activity |